Schond L. Greenway
DFTXSchond L. Greenway serves as Chief Financial Officer at Definium Therapeutics, Inc. (DFTX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.
Schond L. Greenway's Insider Trading at Definium Therapeutics, Inc. (DFTX)
Buys
0 · $0.00
Sells
5 · $208.7K
Total Shares Bought
0
Total Shares Sold
48,609
Schond L. Greenway's Insider Trading at Avalo Therapeutics, Inc. (AVTX)
Buys
2 · $5.3K
Sells
0 · $0.00
Total Shares Bought
2,883
Total Shares Sold
0
Related Insiders
Mittie Doyle
officer: Chief Medical Officer
AVTXSell · Jun 1, 2026
Christopher Ryan Sullivan
officer: Chief Financial Officer
AVTXSell · May 11, 2026
Mitchell Chan
director
AVTXSell · May 7, 2026
VARKI PAUL
officer: Chief Legal Officer
AVTXSell · May 7, 2026
Daniel Karlin
Chief Medical Officer
DFTXSell · Dec 26, 2025
Robert Barrow
Chief Executive Officer
DFTXSell · Dec 26, 2025
Mark Sullivan
Chief Legal Officer
DFTXSell · Dec 26, 2025
Jennifer Riley
Chief Strategy Officer
AVTXSell · Dec 10, 2025